TORONTO and MONTREAL, Nov. 12, 2024 /CNW/ - A proposed Settlement has been reached on behalf of all individuals in Canada who were prescribed and took ABILIFY® before February 23, 2017 ("ABILIFY® ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

H. Lundbeck AS (HLUBF) reports robust financial results with significant growth in strategic brands and a positive outlook for the year.

Accelerated growth for strategic brands (+21% CER) drives revenue up 13% CER in the first nine months of 2024 Key highlights Lundbeck's total revenue grew by +13% CER[1] (+10% DKK) to DKK 16,463 milli ...

Two companies that have been blazing a trail in this field are Otsuka Pharmaceutical Company and Proteus Digital Health, with the co-developed Abilify MyCite (aripiprazole tablets with sensor ...

Alan also contributed to several blockbuster products in collaboration with other companies, such as Abilify with Otsuka and ...

Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Alan Bash as the Company’s President of CARVYKTI ®. In this newly ...

Otsuka Holdings Co ( (OTSKF) ) has released its Q3 earnings. Here is a breakdown of the information Otsuka Holdings Co presented to its ...

Together with Japan's Otsuka Pharmaceuticals, the company produced the ground-breaking smart pill Abilify Mycite (aripiprazole). But the partnership ran into trouble after poor uptake by payers in ...

And withdrawal has been reported in people who took other atypical antipsychotic drugs, such as Abilify (aripiprazole). Withdrawal symptoms reported by people who abruptly stopped taking atypical ...